/Companies

Eldec Pharmaceuticals

Chapel Hill, US · Delaware corporation · 1 known investors

Find your way into Eldec Pharmaceuticals

Each arrow is one introduction. Sign up to fill in the first one.

356 people can intro you to Saira

Ask Fen Zhao to introduce you to Saira Ahmad

You →Fen · together at National Science Foundation →Saira

232 people can intro you to Robert

Ask Jamie Chen to introduce you to Robert Tarran

You →Jamie · together at University of North Carolina at Chapel Hill →Robert

Sign up to find every way you can get introduced to Eldec Pharmaceuticals

  • Your email: who you already know at Eldec Pharmaceuticals, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Eldec Pharmaceuticals team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Eldec is a biotechnology company developing peptide-based therapeutics targeting SPLUNC1's modulation of Orai1 activity, with lead programs ELD615 and ELD607 for lung diseases such as cystic fibrosis and non-CF bronchiectasis. Its research programs are supported by NHLBI, NIAID, NIDDK, and the North Carolina Biotechnology Center.

Founders & leadership

RT
Robert TarranCo-founder · President and CSOHe leads the Division of Genetic, Environmental and Inhalational Disease in the Department of Internal Medicine at the University of Kansas Medical Center, a role he took up in 2023 after nearly two decades at the University of North Carolina at Chapel Hill, where he was a professor in the Department of Cell Biology & Physiology. He was also the scientific founder of Spyryx, a respiratory therapeutics company.
SASaira Ahmad
Saira AhmadCo-founder; Director of ScienceShe joined Eldec Pharmaceuticals in 2018 as a scientist and advanced through senior scientist to her current research leadership role. Her earlier work includes a postdoctoral fellowship and research associate position at the University of North Carolina at Chapel Hill, and doctoral studies at George Mason University, where she also served as a laboratory teaching assistant.
FS
Flori SassanoCo-founder; Director, Research Operations
RJ
Robert J. SchotzingerChairman and Chief Executive Officer
RH
Robert HughesChief Financial Officer
DJ
Dale J. ChristensenChief Development Officer

Investors · 1

Reported raises · per SEC filings

Form D private placements

$200K disclosed across 1 round · 2026

▶$200KraisedFeb 2026 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert TarranExecutive Officer, Director
  • Robert SchotzingerExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$200K
First sale
Feb 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Companies working in the same space as Eldec Pharmaceuticals.

In the news

Frequently asked questions

What does Eldec Pharmaceuticals do?
Eldec is a biotechnology company developing peptide-based therapeutics targeting SPLUNC1's modulation of Orai1 activity, with lead programs ELD615 and ELD607 for lung diseases such as cystic fibrosis and non-CF bronchiectasis. Its research programs are supported by NHLBI, NIAID, NIDDK, and the North Carolina Biotechnology Center.
Who founded Eldec Pharmaceuticals?
Eldec Pharmaceuticals was founded by Robert Tarran, Saira Ahmad, Flori Sassano.
Who are Eldec Pharmaceuticals's investors?
Eldec Pharmaceuticals's investors include Cape Fear BioCapital.
How much funding has Eldec Pharmaceuticals raised?
Eldec Pharmaceuticals has disclosed $200K raised across 1 round.
Where is Eldec Pharmaceuticals headquartered?
Eldec Pharmaceuticals is headquartered in Chapel Hill, US.